Three terms often appear in the same treatment conversation: approved, off-label and compounded. They do not form a simple ladder from good to bad. They describe different features of a medicine and its use. Knowing the distinction helps you ask the right question without drawing a clinical conclusion from a single word.
Approved: a product and its evaluated uses
FDA approval concerns a specific drug product and the uses supported by its reviewed evidence and labeling. Approval does not mean that adverse effects are impossible. FDA describes the decision as a judgment about benefits and risks for the intended use. Start by obtaining the actual product name and the reason it is being prescribed. [Regulatory terminology]
Off-label: an unapproved use of an approved drug
FDA explains that clinicians generally may prescribe an approved drug for an unapproved use when they judge it medically appropriate. The difference can concern the condition treated, dose or route. FDA has not determined safety and effectiveness for that unapproved use. The useful follow-up is to ask what evidence supports the proposal and what alternatives are available. [Regulatory terminology]
A familiar ingredient name does not tell you whether the proposed use matches the product's labeling. Nor does the phrase “off-label” identify the strength of the evidence for a particular situation. That requires a discussion of the actual use, the relevant research and the individual's circumstances.
Compounded: a preparation with a different regulatory status
Compounding involves preparing a medicine for particular needs. Compounded drugs are not FDA-approved and do not undergo FDA's premarket assessment for safety, effectiveness and quality. This is different from using an approved finished drug off-label. Calling both “not approved” without specifying what is unapproved can obscure the distinction. [Compounded-product context]
Identify all three before applying an approval statement or a study result to the offer in front of you.
Check the source of an approval claim
FDA points consumers to Drugs@FDA and the Orange Book to look up approved drugs. Ask a pharmacist for help if a name or presentation is unclear. A company's licensing claim, a pharmacy registration or an ingredient reference is not the same as approval of the finished product being offered. [Official approval lookup guidance]
Turn the terminology into a question
Ask the clinician to explain which category applies, why the option is proposed and what uncertainty remains. Ask the pharmacy to confirm the actual preparation and instructions. FDA's GLP-1 safety information adds concerns specific to unapproved products, so the general definition is only the beginning of the review. This briefing does not determine which category is appropriate for any individual. [Medication safety context]
Source notes
Checked October 5, 2026. Provider pages document advertised terms. Study summaries identify the scope of our review.
- FDA — unapproved uses of approved drugsRegulatory terminology
- FDA — finding out whether a drug is approvedOfficial approval lookup guidance
- FDA — compounding questions and answersCompounded-product context
- FDA — concerns with unapproved GLP-1 productsMedication safety context